(Q46881184)

26 December 2017

title

Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism (English)

1 reference

26 December 2017

0 references

0 references

0 references

0 references

Aysenil Belger

7

0 references

Ralitza Gueorguieva

object named as

Ralitza Gueorguieva

4

0 references

John Krystal

1

object named as

John H Krystal

1 reference

26 December 2017

author name string

Steven Madonick

2

1 reference

26 December 2017

Edward Perry

3

1 reference

26 December 2017

Laura Brush

5

1 reference

26 December 2017

Yola Wray

6

1 reference

26 December 2017

Deepak Cyril D'Souza

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

4 January 2006

1 reference

26 December 2017

published in

Neuropsychopharmacology

1 reference

26 December 2017

volume

31

1 reference

26 December 2017

issue

8

1 reference

26 December 2017

page(s)

1793-1800

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300994

exact match

0 references

cites work

Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Behavioral effects of phencyclidine and ketamine alone and in combination with other drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Failure of ketamine to interact with opiate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Catalepsy induced by combinations of ketamine and morphine: potentiation, antagonism, tolerance and cross-tolerance in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Development and validation of the Biphasic Alcohol Effects Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Experience of a "slip" among alcoholics treated with naltrexone or placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Acamprosate decreases the induction of tolerance and physical dependence in morphine-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

The interaction of ketamine with the opiate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Naltrexone-induced alterations in human ethanol intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Effect of naltrexone on alcohol "high" in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Five-component model of schizophrenia: Assessing the factorial invariance of the positive and negative syndrome scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

Effect of naloxone on the loss of consciousness induced by i.v. anaesthetic agents in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300994

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300994

1 reference

26 December 2017

release_5f4qxyqopbdczgwv4ovm7fsbz4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5f4qxyqopbdczgwv4ovm7fsbz4

24 November 2022

mapped directly with Wikidata item

PubMed ID

16395307

1 reference

26 December 2017